Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant < em > Acinetobacter baumannii < /em > Infections
CONCLUSIONS: SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.PMID:37817550 | DOI:10.1177/10600280231204566 (Source: The Annals of Pharmacotherapy)
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Benjamin August Andrew Matlob Pramodini B Kale-Pradhan Source Type: research
Incorporation of Innovative Strategies for Patient Education in Pharmacist-Led Transition of Care Initiatives
Ann Pharmacother. 2023 Oct 10:10600280231204118. doi: 10.1177/10600280231204118. Online ahead of print.ABSTRACTAs patients transition between health care settings, they are at an increased risk of adverse events and medication errors as a result of medication changes and miscommunication. Pharmacists have traditionally provided transitions of care (TOC) services, including patient education, in a face-to-face manner with the goal of reducing medication errors and enhancing patient safety and understanding. However, changes in care delivery models, a burdened health care workforce, and diminishing resources necessitate inno...
Source: The Annals of Pharmacotherapy - October 11, 2023 Category: Drugs & Pharmacology Authors: Maria Miller Thurston Lori H Dupree Angela Shogbon Nwaesei Lydia C Newsom Source Type: research
